Related references
Note: Only part of the references are listed.Gender, Racial and Ethnic Differences in Pathologic Response Following Neoadjuvant Chemotherapy for Bladder Cancer Patients EDITORIAL COMMENT
Rishi R. Sekar et al.
UROLOGY (2023)
A Consensus Molecular Classification of Muscle-invasive Bladder Cancer
Aurelie Kamoun et al.
EUROPEAN UROLOGY (2020)
Lipid Mediated Regulation of Adult Stem Cell Behavior
Marie Clemot et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Mouse and human urothelial cancer organoids: A tool for bladder cancer research
Jasper Mullenders et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
The androgen receptor regulates a druggable translational regulon in advanced prostate cancer
Yuzhen Liu et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Gata2 as a Crucial Regulator of Stem Cells in Adult Hematopoiesis and Acute Myeloid Leukemia
Juan Bautista Menendez-Gonzalez et al.
STEM CELL REPORTS (2019)
COSMIC: the Catalogue Of Somatic Mutations In Cancer
John G. Tate et al.
NUCLEIC ACIDS RESEARCH (2019)
Genomic distinctions between metastatic lower and upper tract urothelial carcinoma revealed through rapid autopsy
Brian R. Winters et al.
JCI INSIGHT (2019)
Genomic evolution of cancer models: perils and opportunities
Uri Ben-David et al.
NATURE REVIEWS CANCER (2019)
Functional Impact of Chromatin Remodeling Gene Mutations and Predictive Signature for Therapeutic Response in Bladder Cancer
Jason E. Duex et al.
MOLECULAR CANCER RESEARCH (2018)
Tumor Evolution and Drug Response in Patient-Derived Organoid Models of Bladder Cancer
Suk Hyung Lee et al.
CELL (2018)
Phospholipid Remodeling and Cholesterol Availability Regulate Intestinal Stemness and Tumorigenesis
Bo Wang et al.
CELL STEM CELL (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
FATHMM-XF: accurate prediction of pathogenic point mutations via extended features
Mark F. Rogers et al.
BIOINFORMATICS (2018)
Molecular analysis of urothelial cancer cell lines for modeling tumor biology and drug response
M. L. Nickerson et al.
ONCOGENE (2017)
Exploitation of EP300 and CREBBP Lysine Acetyltransferases by Cancer
Narsis Attar et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2017)
Patient-derived xenografts undergo mouse-specific tumor evolution
Uri Ben-David et al.
NATURE GENETICS (2017)
Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer
A. Gordon Robertson et al.
CELL (2017)
Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline
Sam S. Chang et al.
JOURNAL OF UROLOGY (2017)
Tumor-Derived Cell Lines as Molecular Models of Cancer Pharmacogenomics
Andrew Goodspeed et al.
MOLECULAR CANCER RESEARCH (2016)
Paired Exome Analysis Reveals Clonal Evolution and Potential Therapeutic Targets in Urothelial Carcinoma
Philippe Lamy et al.
CANCER RESEARCH (2016)
Spatial Proximity to Fibroblasts Impacts Molecular Features and Therapeutic Sensitivity of Breast Cancer Cells Influencing Clinical Outcomes
Andriy Marusyk et al.
CANCER RESEARCH (2016)
Clonal evolution of chemotherapy-resistant urothelial carcinoma
Bishoy M. Faltas et al.
NATURE GENETICS (2016)
An Epigenomic Approach to Improving Response to Neoadjuvant Cisplatin Chemotherapy in Bladder Cancer
Evanguelos Xylinas et al.
BIOMOLECULES (2016)
Targeted therapies in bladder cancer: an overview of in vivo research
Kim E. M. van Kessel et al.
NATURE REVIEWS UROLOGY (2015)
Patient-derived bladder cancer xenografts in the preclinical development of novel targeted therapies
Wolfgang Jäger et al.
Oncotarget (2015)
HTSeq-a Python framework to work with high-throughput sequencing data
Simon Anders et al.
BIOINFORMATICS (2015)
High-dose chemotherapeutics of intravesical chemotherapy rapidly induce mitochondrial dysfunction in bladder cancer-derived spheroids
Takahiro Yoshida et al.
CANCER SCIENCE (2015)
Dynamics of genomic clones in breast cancer patient xenografts at single-cell resolution
Peter Eirew et al.
NATURE (2015)
Development and Characterization of Bladder Cancer Patient-Derived Xenografts for Molecularly Guided Targeted Therapy
Chong-xian Pan et al.
PLOS ONE (2015)
Targeting GPR30 with G-1: a new therapeutic target for castration-resistant prostate cancer
Hung-Ming Lam et al.
ENDOCRINE-RELATED CANCER (2014)
Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration
Helga Thorvaldsdottir et al.
BRIEFINGS IN BIOINFORMATICS (2013)
Recurrence of high-risk bladder cancer: A population-based analysis
Karim Chamie et al.
CANCER (2013)
Phenotypic and Transcriptional Fidelity of Patient-Derived Colon Cancer Xenografts in Immune-Deficient Mice
Jeffrey Chou et al.
PLOS ONE (2013)
TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions
Daehwan Kim et al.
GENOME BIOLOGY (2013)
A Systematic Review of Neoadjuvant and Adjuvant Chemotherapy for Muscle-invasive Bladder Cancer
Joshua J. Meeks et al.
EUROPEAN UROLOGY (2012)
Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy
Geeta Mehta et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Clonal selection in xenografted human T cell acute lymphoblastic leukemia recapitulates gain of malignancy at relapse
Emmanuelle Clappier et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
edgeR: a Bioconductor package for differential expression analysis of digital gene expression data
Mark D. Robinson et al.
BIOINFORMATICS (2010)
FoxO3 Regulates Neural Stem Cell Homeostasis
Valerie M. Renault et al.
CELL STEM CELL (2009)
Wnt7a Activates the Planar Cell Polarity Pathway to Drive the Symmetric Expansion of Satellite Stem Cells
Fabien Le Grand et al.
CELL STEM CELL (2009)
BRAF mutation predicts sensitivity to MEK inhibition
DB Solit et al.
NATURE (2006)
Regulation of human embryonic stem cell differentiation by BMP-2 and its antagonist noggin
MF Pera et al.
JOURNAL OF CELL SCIENCE (2004)
Share Paper
